Zubia A - Search Results

1

Development and validation of a LC-MS assay for the quantification of ikh12 a novel anti-tumor candidate in rat plasma and tissues and its application in a pharmacokinetic study.

Otaegui D, Masdeu C, Aldaba E, Vara Y, Zubia A, San Sebastian E, Alcalá M, Villafruela S, Cossío FP, Rodriguez-Gascón A. Otaegui D, et al. Among authors: zubia a. Biomed Chromatogr. 2015 Aug;29(8):1249-58. doi: 10.1002/bmc.3414. Epub 2015 Jan 23. Biomed Chromatogr. 2015. PMID: 25616154

2

Development and validation of a liquid chromatography-tandem mass spectrometry for the determination of Kendine 91, a novel histone deacetylase inhibitor, in mice plasma and tissues: application to a pharmacokinetic study.

Otaegui D, Rodríguez-Gascón A, Zubia A, Cossío FP, Pedraz JL. Otaegui D, et al. Among authors: zubia a. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jul 1;870(1):109-16. doi: 10.1016/j.jchromb.2008.06.013. Epub 2008 Jun 13. J Chromatogr B Analyt Technol Biomed Life Sci. 2008. PMID: 18583203

3

Pharmacokinetics and tissue distribution of Kendine 91, a novel histone deacetylase inhibitor, in mice.

Otaegui D, Rodríguez-Gascón A, Zubia A, Cossío FP, Pedraz JL. Otaegui D, et al. Among authors: zubia a. Cancer Chemother Pharmacol. 2009 Jun;64(1):153-9. doi: 10.1007/s00280-008-0857-9. Epub 2008 Nov 11. Cancer Chemother Pharmacol. 2009. PMID: 19002463

4

Design, synthesis, and functional evaluation of leukocyte function associated antigen-1 antagonists in early and late stages of cancer development.

San Sebastián E, Zimmerman T, Zubia A, Vara Y, Martin E, Sirockin F, Dejaegere A, Stote RH, Lopez X, Pantoja-Uceda D, Valcárcel M, Mendoza L, Vidal-Vanaclocha F, Cossío FP, Blanco FJ. San Sebastián E, et al. Among authors: zubia a. J Med Chem. 2013 Feb 14;56(3):735-47. doi: 10.1021/jm3016848. Epub 2013 Jan 22. J Med Chem. 2013. PMID: 23339734

5

In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma.

Pérez-Salvia M, Aldaba E, Vara Y, Fabre M, Ferrer C, Masdeu C, Zubia A, Sebastian ES, Otaegui D, Llinàs-Arias P, Rosselló-Tortella M, Berdasco M, Moutinho C, Setien F, Villanueva A, González-Barca E, Muncunill J, Navarro JT, Piris MA, Cossio FP, Esteller M. Pérez-Salvia M, et al. Among authors: zubia a. Haematologica. 2018 Nov;103(11):e537-e540. doi: 10.3324/haematol.2018.189241. Epub 2018 Jun 7. Haematologica. 2018. PMID: 29880608 Free PMC article. No abstract available.

6

Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity.

Zubia A, Ropero S, Otaegui D, Ballestar E, Fraga MF, Boix-Chornet M, Berdasco M, Martinez A, Coll-Mulet L, Gil J, Cossío FP, Esteller M. Zubia A, et al. Oncogene. 2009 Mar 19;28(11):1477-84. doi: 10.1038/onc.2008.501. Epub 2009 Jan 26. Oncogene. 2009. PMID: 19169274

7

Application of stereocontrolled stepwise [3+2] cycloadditions to the preparation of inhibitors of alpha4beta1-integrin-mediated hepatic melanoma metastasis.

Zubia A, Mendoza L, Vivanco S, Aldaba E, Carrascal T, Lecea B, Arrieta A, Zimmerman T, Vidal-Vanaclocha F, Cossio FP. Zubia A, et al. Angew Chem Int Ed Engl. 2005 May 6;44(19):2903-7. doi: 10.1002/anie.200462497. Angew Chem Int Ed Engl. 2005. PMID: 15827972 No abstract available.

8

Solvent-free thermal and microwave-assisted [3 + 2] cycloadditions between stabilized azomethine ylides and nitrostyrenes. An experimental and theoretical study.

Arrieta A, Otaegui D, Zubia A, Cossío FP, Díaz-Ortiz A, de la Hoz A, Herrero MA, Prieto P, Foces-Foces C, Pizarro JL, Arriortua MI. Arrieta A, et al. Among authors: zubia a. J Org Chem. 2007 Jun 8;72(12):4313-22. doi: 10.1021/jo062672z. Epub 2007 May 17. J Org Chem. 2007. PMID: 17506578

9

Quantitative evaluation of the catalytic activity of dendrimers with only one active center at the core: application to the nitroaldol (Henry) reaction.

Zubia A, Cossío FP, Morao I, Rieumont M, Lopez X. Zubia A, et al. J Am Chem Soc. 2004 Apr 28;126(16):5243-52. doi: 10.1021/ja039888s. J Am Chem Soc. 2004. PMID: 15099109

10

A weekly alternating diet between caloric restriction and medium fat protects the liver from fatty liver development in middle-aged C57BL/6J mice.

Rusli F, Boekschoten MV, Zubia AA, Lute C, Müller M, Steegenga WT. Rusli F, et al. Among authors: zubia aa. Mol Nutr Food Res. 2015 Mar;59(3):533-43. doi: 10.1002/mnfr.201400621. Epub 2015 Jan 21. Mol Nutr Food Res. 2015. PMID: 25504628 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page